Abstract
In 1973, Tuttle and Mills [1] developed a new synthetic catecholamine in order to obtain a molecule with a selective inotropic effect and moderate chronotropic, arrhythmogenic and vascular side effects. Twenty years after its birth, dobutamine is not only widely administred as a therapeutic agent but it is increasingly used as a diagnostic tool. Dobutamine has dose-dependent effects. At low dose, it can bring out the contractile reserve of viable myocardium in patients with acute myocardial infarction or chronic coronary artery disease (CAD). At higher doses, the drug still produces intense positive inotropic effects, but the development of tachycardia leads to an increase in myocardial oxygen consumption which can induce ischemia in myocardial regions perfused by arteries with reduced coronary flow reserve.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tuttle RR, Mills J (1975) Development of a new catecholamine to selectively increase cardiac contractility. Circ Res 36: 185–196
Leier CV, Unverferth DV (1983) Dobutamine. Ann Intern Med 99: 490–496
Meyer SL, Curry GR, Donsky MS, Twieg DB, Parkey PW, Willerson JT (1976) Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol 38: 103–108
Regnier B, Safran D, Cadet J, Tesseire B (1979) Comparative hemodynamic effects of dopamine and dobutamine in septic shock. Intensive Care Med 5: 115–120
Jardin F, Sportiche M, Bazine M, Bourobka A, Margairaz A (1981) Dobutamine: A hemodynamic evaluation in human septic shock. Crit Care Med 9: 329–332
Vatner SF, Baig H (1979) Importance of heart rate in determining the effects of sympathomimetic amines on regional myocardial function and blood flow in conscious dogs with acute myocardial ischemia. Circ Res 45: 793–803
Rude RE, Izquierdo C, Buja M, Willerson JT (1982) Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. Studies with dobutamine in the anesthetized dog. Circulation 65: 1321–1328
Braunwald E, Kloner RA (1982) The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 66: 1146–1149
Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117: 211–213
Heyndrickx GR, Millard RW, Mc Ritchie RJ, Maroko PR, Vatner SF (1975) Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 56: 978–985
Nicklas JM, Becker LC, Bulkley BH (1985) Effects of repeated brief coronary occlusion on regional left ventricular function and dimension in dog. Am J Cardiol 56: 473–478
Ellis SG, Heuschke C, Sandor T, Wynne J, Braunwald E, Kloner RA (1983) Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1: 1047–1055
Sheehan FH, Mathey DG, Schofer J, Dodge HT, Bolson EL (1985) Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction. Circulation 71: 1121–1128
Scognamiglio R, Ponchia A, Fasoli G, Miraglia G, Dalla Volta S (1991) Exercise-induced left ventricular dysfunction in coronary artery disease: A model for studying the stunned myocardium in man. Eur Heart J 12 (Suppl. G): 6–19
Breisblatt WM, Stein KL, Wolfe CJ, et al (1990) Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery. J Am Coli Cardiol 15: 1261–1269
Bolli R (1988) Oxygen-derived free radicals and postischemic myocardial dysfunction (“stunned myocardium”). J Am Coli Cardiol 12: 239–249
Kusuoka H, Marban E (1992) Cellular mechanisms of myocardial stunning. Ann Rev Physiol 54: 243–256
Bolli R, Zhu WX, Myers ML, Hartley CJ, Roberts R (1985) Beta adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration. Am J Cardiol 56: 964–968
Pierard LA, de Landsheere CM, Berthe C, Rigo P, Kulbertus HE (1990) Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coli Cardiol 15: 1021–1031
Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S (1991) Low dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 122: 1522–1531
Smart SC, Sawada S, Ryan T, et al (1993) Low dose dobutamine echo cardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 88: 405–415
Skelenar J, Villanueva FS, Glasheen WP, Ismail S, Goodman NC, Kaul S (1994) Dobutamine echo cardiography for detecting the extent of myocardial salvage after reperfusion: An experimental evaluation. Circulation 90: 1503–1512
Rahimtoola SH (1982) Coronary bypass surgery for chronic angina - 1981: A perspective. Circulation 65: 225–230
Tillisch J, Brunken R, Marshal R, et al (1986) Reversibility of cardiac wall motion abnormalities predicted by positron tomography. New Engl J Med 314: 884–888
Schulz R, Guth BD, Pieper K, Martin C, Heusch G (1992) Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation. Circ Res 70: 1282–1295
Schulz R, Rose J, Martin C, Brodde OE, Heusch G (1993) Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation 88: 684–695
Vanoverschelde JLJ, Wijns W, Depre C, et al (1993) Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of non-infarcted collateral-dependent myocardium. Circulation 87: 1513–1523
Cigarroa CG, De Filippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA (1993) Dobutamine stress echo cardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 88: 430–436
La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O (1994) Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coli Cardiol 23: 617–626
Afridi I, Kleiman NS, Raizner AE, Zoghbi WA (1995) Dobutamine echo cardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91: 663–670
Dilsizian V, Bonow RO (1993) Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 87: 1–20
Waltier DC, Zyvoloski M, Gross GJ, Hardman HF, Brooks HL (1981) Redistribution of myocardial blood flow distal to a dynamic coronary arterial stenosis by sympathomimetic amines. Am J Cardiol 48: 269–279
McNeill AJ, Fioretti PM, El Said ESM, Salustri A, Forster T, Roelandt JRTC (1992) Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 70: 41–46
Pierard LA, Berthe C, Albert A, Carlier J, Kulbertus HE (1989) Haemodynamic alterations during ischaemia induced by dobutamine stress testing. Eur Heart J 10: 783–790
Mertes H, Sawada SG, Ryan T, et al (1993) Symptoms, adverse effects and complications associated with dobutamine stress echo cardiography - Experience in 1118 patients. Circulation 88: 15–19
Coma-Canella I (1991) Dobutamine stress test to diagnose the presence and severity of coronary artery lesions in angina. Eur Heart J 12: 1198–1204
Mairesse GH, Marwick TH, Vanoverschelde JLJ, et al (1994) How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echo cardiography and technetium-99m, methoxyl isobutyl isonitrile (Mibi) perfusion scintigraphy. J Am Coll Cardiol 24: 920–927
Berthe C, Pierard LA, Hiernaux M, et al (1986) Predicting the extent and location of coronary artery disease in acute myocardial infarction by echo cardiography during dobutamine infusion. Am J Cardiol 58: 1167–1172
Sawada SG, Segar DS, Ryan T, et al (1991) Echocardiographic dectection of coronary artery disease during dobutamine infusion. Circulation 83: 1605–1614
Galiuto L, Legrand V, Martinez C, Berthe C, Pierard L (1994) Assessment of severity of coronary narrowings by quantitative dobutamine echo cardiography. Acta Cardiologica 49: 101–102
Pennell DJ, Underwood SR, Manzara CC, et al (1992) Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 70: 34–40
Van Rugge FP, Van der Wall EE, De Roos A, Bruschke AVG (1993) Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol 22: 431–439
Mason JR, Palac RT, Freeman ML, et al (1984) Thallium scintigraphy during dobutamine infusion: Non-exercise-dependent screening test for coronary disease. Am Heart J 107: 481–489
Pennell DJ, Underwood SR, Swanton RH, Walker JM, Ell PJ (1991) Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 18: 1471–1479
Marwick T, D’Hondt AM, Baudhuin T, et al (1993) Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography or scintigraphy or both? J Am Coll Cardiol 22: 159–167
Forster T, McNeill AJ, Salustri A, et al (1993) Simultaneous dobutamine stress echo cardiography and technetium 99m isonitrile single photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 21: 1591–1596
Segar DS, Brown SE, Sawada SG, Ryan T, Feigenbaum H (1992) Dobutamine stress echo cardiography: Correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 19: 1197–1202
Pierard LA, Berthe C, Larock MP, et al (1992) Detection of residual ischaemia in the infarct zone and at a distance in myocardial infarction: Comparison of dobutamine stress echocardiography with dobutamine stress Tc-MIBI scintigraphy. J Am Coll Cardiol 19: 81A (Abst)
Coma Canella I, Del Val Gomez Martinez M, Rodrigo F, Castro Beiras JM (1993) The dobutamine stress test with thallium 201 single photon emission computed tomography and radionuclide angiography: Post-infarction study. J Am Coll Cardiol 22: 399–406
Massie BM, Mangano DT (1993) Risk stratification for non cardiac surgery. How (and why)? Circulation 87: 1752–1754
Poldermans D, Fioretti PM, Forster T, et al (1993) Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 87: 1506–1512
Davila-Roman VG, Waggoner AD, Sicard GA, Geltman EM, Schechtman KB, Perez JE (1993) Dobutamine stress echo cardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 21: 957–963
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Galiuto, L., Pierard, L.A. (1996). Detection of Myocardial Viability and Inducible Ischemia with Dobutamine. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80053-5_48
Download citation
DOI: https://doi.org/10.1007/978-3-642-80053-5_48
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60552-2
Online ISBN: 978-3-642-80053-5
eBook Packages: Springer Book Archive